Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales: 2009-2024

Historic Return on Sales for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 0.29%.

  • Ironwood Pharmaceuticals' Return on Sales rose 99.00% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 99.00%. This contributed to the annual value of 0.29% for FY2024, which is 313.00% up from last year.
  • As of FY2024, Ironwood Pharmaceuticals' Return on Sales stood at 0.29%, which was up 110.29% from -2.84% recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Sales peaked at 1.28% during FY2021, and registered a low of -2.84% during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Return on Sales averaged around -0.71%, with its median value being 0.29% (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Return on Sales slumped by 327bps in 2023 and then spiked by 313bps in 2024.
  • Ironwood Pharmaceuticals' Return on Sales (Yearly) stood at 0.27% in 2020, then surged by 100bps to 1.28% in 2021, then plummeted by 85bps to 0.43% in 2022, then plummeted by 327bps to -2.84% in 2023, then spiked by 313bps to 0.29% in 2024.